-
A panel of experts voted to recommend that the Food and Drug Administration authorize a booster dose of the Johnson & Johnson COVID vaccine at least two months after the first shot.
-
Johnson & Johnson has asked the Food and Drug Administration to authorize a booster for people 18 and older six months after initial immunization, with an option to vaccinate after two months.
-
The Food and Drug Administration released briefing documents Tuesday on booster shots for the Moderna and Johnson & Johnson COVID vaccines ahead of a two-day advisory meeting that starts Thursday.
-
A panel of FDA advisers meets next week to consider boosters for both Johnson & Johnson and Moderna vaccines.
-
Boosters are available for higher-risk people who got the Pfizer vaccine. But what about people who got the one-shot Johnson & Johnson? Some doctors say they need an extra shot even more urgently.
-
How much the vaccine manufacturers stand to gain depends on how big the rollout proves to be.
-
Johnson & Johnson shared data from its Phase 3 trial of the company's booster shot on Tuesday. The data showed a booster shot at six months provided a 12-fold increase in antibodies.
-
But the researchers stressed that all three vaccines, including the Pfizer and Johnson & Johnson shots, provide strong protection against people getting so sick that they end up in the hospital.
-
Johnson & Johnson said that when it gave study participants a second jab after six months, their antibody levels were nine times higher than they were 28 days after a first dose of the COVID vaccine.
-
The complaint claims Johnson & Johnson made Black women a "central part" of its business strategy but failed to warn them about the potential dangers of the powder products it was selling.